Zevra Therapeutics to Present New Long-Term Real-World Data on MIPLYFFA in NPC
Zevra Therapeutics (ZVRA) says it will present new long-term real-world data on MIPLYFFA® for Niemann-Pick disease type C (NPC) at the 2026 SSIEM Annual Symposium.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.